Literature DB >> 21591710

Rapid high-resolution characterization of functionally important monoclonal antibody N-glycans by capillary electrophoresis.

Zoltan Szabo1, András Guttman, Jonathan Bones, Barry L Karger.   

Abstract

Characterization of the N-glycosylation present in the Fc region of therapeutic monoclonal antibodies requires rapid, high-resolution separation methods to guarantee product safety and efficacy during all stages of process development. Determination of fucosylated oligosaccharides is particularly important during clone selection, product characterization, and lot release as fucose has been shown to adversely affect the ability of mAbs to induce antibody dependent cellular cytotoxicity (ADCC). Here, we apply a general capillary electrophoresis optimization strategy to separate functionally relevant fucosylated and afucosylated glycans on mononclonal antibody products in the presence of several high mannose oligosaccharides. The N-glycans chosen represent those most commonly reported on CHO cell derived therapeutic antibodies. A rapid (<7 min) high-resolution separation of 12 commonly reported and functionally important IgG glycans was developed by systematically evaluating the effects of selectivity (boric acid) and efficiency (linear polyacrylamide) enhancing additives. The approach can be used to rapidly optimize capillary electrophoresis separation of other glycan mixtures. Following optimization, the method was applied to overnight sample processing for automated 96 well plate-based glycosylation analyses of two nonproprietary therapeutic monoclonal antibodies, demonstrating ruggedness and suitability for high-throughput process and product monitoring applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21591710      PMCID: PMC3128192          DOI: 10.1021/ac2007587

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  12 in total

1.  Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies.

Authors:  Satoru Kamoda; Rika Ishikawa; Kazuaki Kakehi
Journal:  J Chromatogr A       Date:  2006-09-01       Impact factor: 4.759

2.  Harnessing electrical forces for separation. Capillary zone electrophoresis, isoelectric focusing, field-flow fractionation, split-flow thin-cell continuous-separation and other techniques.

Authors:  J C Giddings
Journal:  J Chromatogr       Date:  1989-10-20

3.  High capacity capillary electrophoresis-electrospray ionization mass spectrometry: coupling a porous sheathless interface with transient-isotachophoresis.

Authors:  Jean-Marc Busnel; Bart Schoenmaker; Rawi Ramautar; Alegria Carrasco-Pancorbo; Chitra Ratnayake; Jerald S Feitelson; Jeff D Chapman; André M Deelder; Oleg A Mayboroda
Journal:  Anal Chem       Date:  2010-10-28       Impact factor: 6.986

4.  High-resolution carbohydrate profiling by capillary gel electrophoresis.

Authors:  A Guttman
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

5.  The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.

Authors:  Claudia Ferrara; Fiona Stuart; Peter Sondermann; Peter Brünker; Pablo Umaña
Journal:  J Biol Chem       Date:  2005-12-05       Impact factor: 5.157

6.  Improved sample preparation method for glycan analysis of glycoproteins by CE-LIF and CE-MS.

Authors:  Zoltan Szabo; András Guttman; Tomas Rejtar; Barry L Karger
Journal:  Electrophoresis       Date:  2010-04       Impact factor: 3.535

7.  Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics.

Authors:  T S Raju; J B Briggs; S M Borge; A J Jones
Journal:  Glycobiology       Date:  2000-05       Impact factor: 4.313

8.  Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds.

Authors:  David J Harvey; Anthony H Merry; Louise Royle; Matthew P Campbell; Raymond A Dwek; Pauline M Rudd
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

Review 9.  Monoclonal antibody "gold rush".

Authors:  Krishan Maggon
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 10.  Glycosylation as a strategy to improve antibody-based therapeutics.

Authors:  Roy Jefferis
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

View more
  11 in total

Review 1.  High-sensitivity analytical approaches for the structural characterization of glycoproteins.

Authors:  William R Alley; Benjamin F Mann; Milos V Novotny
Journal:  Chem Rev       Date:  2013-03-27       Impact factor: 60.622

Review 2.  Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.

Authors:  Kerry M Wooding; Wenjing Peng; Yehia Mechref
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

Review 3.  Structural glycomic analyses at high sensitivity: a decade of progress.

Authors:  William R Alley; Milos V Novotny
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2013-04-03       Impact factor: 10.745

4.  Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals.

Authors:  Seshu Tummala; Michael Titus; Lee Wilson; Chunhua Wang; Carlo Ciatto; Greg Thill; Donald Foster; Chen Li; Zoltan Szabo; Andras Guttman; Brian Bettencourt; Muthuswamy Jayaraman; Jack Deroot; David Kocisko; Stuart Pollard; Klaus Charisse; Satya Kuchimanchi; Greg Hinkle; Stuart Milstein; Rachel Meyers; Shiaw-Lin Wu; Barry L Karger; Anthony Rossomando
Journal:  Biotechnol Prog       Date:  2013-02-13

Review 5.  Analytical glycobiology at high sensitivity: current approaches and directions.

Authors:  Milos V Novotny; William R Alley; Benjamin F Mann
Journal:  Glycoconj J       Date:  2012-09-04       Impact factor: 2.916

6.  Ultrasensitive capillary electrophoretic analysis of potentially immunogenic carbohydrate residues in biologics: galactose-α-1,3-galactose containing oligosaccharides.

Authors:  Zoltan Szabo; Andras Guttman; Jonathan Bones; Randi L Shand; David Meh; Barry L Karger
Journal:  Mol Pharm       Date:  2012-05-15       Impact factor: 4.939

7.  The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.

Authors:  Pauline Estupina; Alexandre Fontayne; Jean-Marc Barret; Nathalie Kersual; Olivier Dubreuil; Marion Le Blay; Alexandre Pichard; Marta Jarlier; Martine Pugnière; Maëva Chauvin; Thierry Chardès; Jean-Pierre Pouget; Emmanuel Deshayes; Alexis Rossignol; Toufik Abache; Christophe de Romeuf; Aurélie Terrier; Lucie Verhaeghe; Christine Gaucher; Jean-François Prost; André Pèlegrin; Isabelle Navarro-Teulon
Journal:  Oncotarget       Date:  2017-06-06

8.  Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.

Authors:  Sebastian Miethe; Christelle Mazuet; Yvonne Liu; Robert Tierney; Christine Rasetti-Escargueil; Arnaud Avril; André Frenzel; Philippe Thullier; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Dorothea Sesardic; Michael Hust; Michel Robert Popoff
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

9.  Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.

Authors:  Yağmur Derman; Katja Selby; Sebastian Miethe; André Frenzel; Yvonne Liu; Christine Rasetti-Escargueil; Arnaud Avril; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Philippe Thullier; Dorothea Sesardic; Miia Lindström; Michael Hust; Hannu Korkeala
Journal:  Toxins (Basel)       Date:  2016-09-12       Impact factor: 4.546

10.  Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.

Authors:  Nathalie Fournier; Emilie Jacque; Alexandre Fontayne; Delphine Derache; Gilles Dupont; Lucie Verhaeghe; Linda Baptista; Aurélie Dehenne; Anne-Sophie Dezetter; Aurélie Terrier; Alain Longue; Virginie Pochet-Beghin; Cecile Beghin; Sami Chtourou; Christophe de Romeuf
Journal:  MAbs       Date:  2018-04-10       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.